1
|
Bolton DL, Minang JT, Trivett M, Song K, Tuscher JJ, Li Y, Piatak M, O'Connor D, Lifson JD, Roederer M, Ohlen C. Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaques. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2010; 184:303-14. [PMID: 19949089 PMCID: PMC2797565 DOI: 10.4049/jimmunol.0902413] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Despite multiple lines of evidence suggesting their involvement, the precise role of CD8(+) T cells in controlling HIV replication remains unclear. To determine whether CD8(+) T cells can limit retroviral replication in the absence of other immune responses, we transferred 1-13 x 10(9) allogeneic in vitro expanded SIV-specific CD8(+) T cell clones matched for the relevant restricting MHC-I allele into rhesus macaques near the time of i.v. SIV challenge. Additionally, in vitro expanded autologous SIV-specific CD8(+) T cell clones were infused 4-9 mo postinfection. Infused cells did not appreciably impact acute or chronic viral replication. The partially MHC-matched allogeneic cells were not detected in the blood or most tissues after 3 d but persisted longer in the lungs as assessed by bronchoalveolar lavage (BAL). Autologous cells transferred i.v. or i.p. were found in BAL and blood samples for up to 8 wk postinfusion. Interestingly, despite having a nominally activated phenotype (CD69(+)HLA-DR(+)), many of these cells persisted in the BAL without dividing. This suggests that expression of such markers by T cells at mucosal sites may not reflect recent activation, but may instead identify stable resident memory T cells. The lack of impact following transfer of such a large number of functional Ag-specific CD8(+) T cells on SIV replication may reflect the magnitude of the immune response required to contain the virus.
Collapse
Affiliation(s)
- Diane L. Bolton
- ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892
| | - Jacob T. Minang
- AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD 21702
| | - Matt Trivett
- AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD 21702
| | - Kaimei Song
- ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892
| | - Jennifer J. Tuscher
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53711
| | - Yuan Li
- AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD 21702
| | - Michael Piatak
- AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD 21702
| | - David O'Connor
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53711
| | - Jeffrey D. Lifson
- AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD 21702
| | - Mario Roederer
- ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892
| | - Claes Ohlen
- AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD 21702
| |
Collapse
|